Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8849 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8849 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8786 |
High Similarity |
NPD1549 |
Phase 2 |
0.869 |
High Similarity |
NPD5403 |
Approved |
0.8681 |
High Similarity |
NPD5401 |
Approved |
0.8649 |
High Similarity |
NPD1934 |
Approved |
0.8611 |
High Similarity |
NPD6799 |
Approved |
0.8552 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD7075 |
Discontinued |
0.8514 |
High Similarity |
NPD4380 |
Phase 2 |
0.8493 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8467 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8452 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8417 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8411 |
Intermediate Similarity |
NPD5402 |
Approved |
0.84 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.838 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8356 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8355 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.831 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8298 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8291 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8224 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8187 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.817 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8137 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8088 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8086 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8063 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8052 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8015 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8012 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7933 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7847 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7838 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7785 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7762 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7754 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7754 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7746 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7658 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7597 |
Intermediate Similarity |
NPD920 |
Approved |
0.7591 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7562 |
Intermediate Similarity |
NPD919 |
Approved |
0.7561 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD290 |
Approved |
0.7551 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD411 |
Approved |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7483 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7481 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7468 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7466 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD3748 |
Approved |
0.745 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD943 |
Approved |
0.741 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.74 |
Intermediate Similarity |
NPD6100 |
Approved |
0.74 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7379 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7338 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7294 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7292 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7279 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7273 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD2654 |
Approved |
0.725 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7235 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7111 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7111 |
Intermediate Similarity |
NPD74 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7075 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7069 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7055 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7037 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7037 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7037 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7017 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7013 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7 |
Intermediate Similarity |
NPD520 |
Approved |
0.6994 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD1778 |
Approved |
0.6993 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD2684 |
Approved |
0.6981 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.698 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6974 |
Remote Similarity |
NPD6653 |
Approved |
0.6973 |
Remote Similarity |
NPD7584 |
Approved |
0.6971 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6963 |
Remote Similarity |
NPD968 |
Approved |
0.6959 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6957 |
Remote Similarity |
NPD2651 |
Approved |
0.6957 |
Remote Similarity |
NPD2649 |
Approved |
0.6954 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6954 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.695 |
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6943
|
Remote Similarity |
NPD6190 |
Approved |